2BB score and signals
Eupraxia Pharmaceuticals Inc.’s current 2BB score is 50 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 61 | High |
| Momentum | 69 | Improving |
| Financial strength | 48 | Normal |
| Quality | 55 | Normal |
| Risk | 48 | Moderate |
Company facts
| Headquarters | Victoria, British Columbia, Canada |
| Founded | 2011 |
| Employees | 49 |
| 52-week range | $5.25 – $9.31 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-08-07 | — | -0.2346 | — | $0.00 |
| 2026-05-12 | -0.23 | -0.2278 | $0.00 | $0.00 |
| 2026-03-12 | -0.37024 | -0.1741 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish